Frankfurt - Delayed Quote • EUR Madrigal Pharmaceuticals, Inc. (YDO1.F) Follow Add holdings 259.10 +0.90 +(0.35%) As of 5:00:01 PM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for YDO1.F 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: YDO1.F View More All News Press Releases SEC Filings John Paulson's Strategic Move: Honeywell International Inc. Takes Center Stage 2 Monster Stocks in the Making to Buy Now and Hold for 10 Years Madrigal Announces New Clinical Data Demonstrating Rezdiffra™ (resmetirom) Significantly Improved Multiple Noninvasive Tests and Portal Hypertension Risk in Patients with Compensated MASH Cirrhosis Madrigal Pharmaceuticals, Inc. (MDGL): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential Madrigal Pharmaceuticals (MDGL): Among Billionaire John Paulson’s Stocks with Huge Upside Potential Madrigal Pharmaceuticals Inc (MDGL) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ... Q1 2025 Madrigal Pharmaceuticals Inc Earnings Call Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up Madrigal: Q1 Earnings Snapshot Madrigal’s MASH drug sales again top Wall Street projections Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates Related Tickers 0OT.F Ocular Therapeutix, Inc. 6.41 +5.74% 1VT.BE Viking Therapeutics Inc 25.08 +2.70% OCUL Ocular Therapeutix, Inc. 7.18 +0.14% ACAD ACADIA Pharmaceuticals Inc. 23.47 +33.35% ALT Altimmune, Inc. 5.73 -0.88% VKTX Viking Therapeutics, Inc. 28.11 +2.59%